Cochrane · systematic review · CD015253
Autoinflation for otitis media with effusion (OME) in children
Webster, KE, Mulvaney, CA, Galbraith, K, et al. · Cochrane Database of Systematic Reviews · 2023 · Cochrane Library
ENTAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
4
current version
GRADE rated
4
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 2 · 50%Low 2 · 50%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Autoinflation compared to no treatment for otitis media with effusion (OME) in children
Population: otitis media with effusion (OME) in children aged 6 months to 12 years
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Proportion of children whose hearing is normal Autoinflation vs no treatment | RR 2.67 [1.73, 4.12] | NR | Very low Downgraded: risk of bias |
Disease‐specific quality of life Mean difference in standardised OMQ‐14 scores (lower score is favourable) Autoinflation vs no treatment | no estimate extracted | NR | Low Downgraded: risk of bias |
Pain and distress related to the procedure: otalgia Autoinflation vs no treatment | RR 3.5 [0.74, 16.59] | NR | Very low Downgraded: risk of bias |
Persistence of OME Autoinflation vs no treatment | RR 0.88 [0.8, 0.97] | NR | Low Downgraded: risk of bias |